St. Paul, MN (October 12, 2001)--The American Phytopathological Society (APS), the world's largest organization of plant health scientists, has issued a formal statement in support of biotechnology. Citing the enormous potential benefits to humanity possible through biotechnology, while advocating responsible and science-based oversight and regulation, the APS members hope to call attention to the importance of biotechnology in their work.

"Virtually all aspects of plant pathology are affected by biotechnology," states Sue Tolin, a plant pathologist with Virginia Polytechnic Institute and State University and a member of the APS Public Policy Board. "Advances in this area have played a critical role in our ability to identify and control plant pathogens that cause billions of dollars of crop losses each year, particularly in developing countries where diseases routinely destroy important food crops."

Among the benefits outlined in the APS statement are the environmental positives promised through biotechnology. Plant pathologists point out that biotechnology is an important tool for reducing dependence of growers on synthetic pesticides for controlling plant diseases, and minimizing adverse environmental impacts of modern agriculture practices. The statement also calls for placing consideration of risks associated with plant disease management through biotechnology in perspective with other disease management approaches, including social, economic, and environmental issues and concerns.

"Biotechnology must be practiced in a responsible way, respectful of human, economic and environmental impacts," states Noel Keen, current APS President. "We believe it would be an enormous setback if we were unable to continue the progress we've already made." APS, he says, created and issued their statement at this time to underscore the substantial contribution biotechnology has made to the understanding and control of plant diseases, and to stress the important role it can play in future advancements.

The American Phytopathological Society (APS) is a non-profit, professional scientific organization dedicated to the study and control of plant disease with 5,000 members worldwide. The APS Statement on Biotechnology and its Application to Plant Pathology is available for your review in its entirety at http://www.apsnet.org/members/ppb/ps/
APS%20Biotech%20Statement.pdf

Contact Molly Cerny or 651.454.7250 for a copy

++++ APS Statement

The American Phytopathological Society's (APS) governing Council approved on August 29, 2001 a statement expressing its position on biotechnology. The APS Public Policy Board recommended an initial draft of this statement to Council. The approved statement acknowledges the many benefits of using biotechnology for plant pathogen and plant research and for disease management. It also expresses support for responsible and science-based oversight and regulation of biotechnology. Further, it calls for placing consideration of risks associated with managing plant diseases through biotechnology in perspective with other disease management approaches, including social, economic, and environmental issues and concerns. The following is the approved statement.

APS Statement on Biotechnology and its Application to Plant Pathology The American Phytopathological Society (APS), which represents approximately 5,000 scientists who work with plant pathogens, the diseases they cause, and ways of controlling them, supports biotechnology as a means for improving plant health, food safety, and sustainable growth in plant productivity. Virtually all aspects of plant pathology are affected by biotechnology, a term which includes recombinant DNA technology and other new genetic technologies. Early fundamental research in plant pathology provided the foundation from which plant biotechnology emerged. Genome segments from plant pathogenic viruses and bacteria are widely used as vectors into which genes are inserted to make transgenic plants. Insertion of viral sequences into the plant genome causes the plant to resist virus infection through a process akin to immunization, providing an effective new genetic approach for managing plant viruses. Biotechnology and genomic approaches have enhanced the process of identifying plant pathogens with greater accuracy, a prerequisite for managing the diseases they cause.

Plant genes and gene products that interact with pathogens have been identified and either inserted into plants or used as specific molecular markers to enhance plant breeding for resistance. Reduced insect feeding on Bt-corn, produced through biotechnology, has also been found to result in fewer fungal infections and less toxin production. Thus the information learned from applying biotechnology to plant pathogens and to plant-pathogen interactions is providing new knowledge and new approaches to improve plant health and increase the yield and quality of plants contributing to food, feed and fiber. Future environmental benefits of biotechnology for improved management of plant diseases are enormous, particularly the potential to reduce the dependency of commercial and non-commercial growers on synthetic pesticides, and enhance approaches that minimize adverse effects on the environment.

The concerns that are being raised of environmental and food safety risks of biotechnology through gene exchange and evolution of new pathogens, or from putative increased or unexpected allergenicity are legitimate risks that will be addressed as have similar potential risks with any new plant or plant product. Assessment and management of these and other risks of new technologies in a formal process is appropriate, and must be conducted in a science-based manner and also include economic, human and animal health, and ecological consequences. However, these risks and concerns are not limited to plants and plant products produced through biotechnology and thus must be placed in perspective. The consequences of foregoing the use of biotechnology for improving plant health and sustainable plant productivity must also be considered.

Copyright © 2006. CropBiotech Net.